American International Group Inc. Has $5.57 Million Stock Position in Envista Holdings Co. (NYSE:NVST)

American International Group Inc. raised its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 0.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 231,461 shares of the company’s stock after buying an additional 650 shares during the quarter. American International Group Inc. owned about 0.13% of Envista worth $5,569,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Envestnet Asset Management Inc. lifted its stake in shares of Envista by 276.8% in the third quarter. Envestnet Asset Management Inc. now owns 175,141 shares of the company’s stock valued at $4,883,000 after buying an additional 128,656 shares during the period. Algert Global LLC acquired a new stake in shares of Envista during the 3rd quarter worth approximately $748,000. Covestor Ltd grew its holdings in shares of Envista by 33.9% during the 3rd quarter. Covestor Ltd now owns 2,462 shares of the company’s stock worth $69,000 after purchasing an additional 624 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Envista by 5.0% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 117,921 shares of the company’s stock valued at $3,288,000 after purchasing an additional 5,610 shares during the period. Finally, Itau Unibanco Holding S.A. acquired a new position in shares of Envista in the third quarter valued at $47,000.

Envista Price Performance

Shares of NVST stock opened at $17.41 on Friday. Envista Holdings Co. has a 52 week low of $16.74 and a 52 week high of $36.14. The stock has a market capitalization of $2.99 billion, a PE ratio of -24.18, a PEG ratio of 13.84 and a beta of 1.34. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.93 and a current ratio of 2.27. The stock’s fifty day moving average is $18.80 and its 200-day moving average is $21.33.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.05). Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. The company had revenue of $623.60 million for the quarter, compared to the consensus estimate of $634.85 million. During the same period in the prior year, the company earned $0.38 EPS. The firm’s revenue was down .6% compared to the same quarter last year. Equities research analysts expect that Envista Holdings Co. will post 1.23 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

NVST has been the topic of several analyst reports. Robert W. Baird lowered their price target on shares of Envista from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Thursday, May 2nd. JPMorgan Chase & Co. dropped their price target on shares of Envista from $29.00 to $23.00 and set an “overweight” rating for the company in a research report on Thursday, May 2nd. The Goldman Sachs Group decreased their price objective on Envista from $20.00 to $17.50 and set a “sell” rating on the stock in a report on Friday, May 3rd. Morgan Stanley cut Envista from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $33.00 to $21.00 in a report on Friday, April 26th. Finally, Needham & Company LLC restated a “hold” rating on shares of Envista in a research report on Monday, June 3rd. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $25.86.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.